These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


98 related items for PubMed ID: 8127531

  • 1. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.
    Gambacciani M, Spinetti A, Taponeco F, Cappagli B, Piaggesi L, Fioretti P.
    Obstet Gynecol; 1994 Mar; 83(3):392-6. PubMed ID: 8127531
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
    Gambacciani M, Cappagli B, Lazzarini V, Ciaponi M, Fruzzetti F, Genazzani AR.
    Maturitas; 2006 May 20; 54(2):176-80. PubMed ID: 16332417
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal evaluation of perimenopausal femoral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.
    Gambacciani M, Ciaponi M, Cappagli B, Benussi C, Genazzani AR.
    Osteoporos Int; 2000 May 20; 11(6):544-8. PubMed ID: 10982172
    [Abstract] [Full Text] [Related]

  • 4. Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics.
    Gambacciani M, Cappagli B, Ciaponi M, Benussi C, Genazzani AR.
    Menopause; 1999 May 20; 6(1):43-8. PubMed ID: 10100179
    [Abstract] [Full Text] [Related]

  • 5. Bone mineral density and history of oral contraceptive use.
    Fortney JA, Feldblum PJ, Talmage RV, Zhang J, Godwin SE.
    J Reprod Med; 1994 Feb 20; 39(2):105-9. PubMed ID: 8169923
    [Abstract] [Full Text] [Related]

  • 6. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Feb 20; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 7. The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
    Arrenbrecht S, Caubel P, Garnero P, Felsenberg D.
    Maturitas; 2004 Jul 15; 48(3):197-207. PubMed ID: 15207885
    [Abstract] [Full Text] [Related]

  • 8. Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women.
    Paoletti AM, Orrù M, Lello S, Floris S, Ranuzzi F, Etzi R, Zedda P, Guerriero S, Fratta S, Sorge R, Mallarini G, Melis GB.
    Contraception; 2004 Oct 15; 70(4):293-8. PubMed ID: 15451333
    [Abstract] [Full Text] [Related]

  • 9. Effects of two low-dose combined oral contraceptives containing drospirenone on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
    Gargano V, Massaro M, Morra I, Formisano C, Di Carlo C, Nappi C.
    Contraception; 2008 Jul 15; 78(1):10-5. PubMed ID: 18555812
    [Abstract] [Full Text] [Related]

  • 10. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study.
    Löfman O, Magnusson P, Toss G, Larsson L.
    Clin Chim Acta; 2005 Jun 15; 356(1-2):67-75. PubMed ID: 15936304
    [Abstract] [Full Text] [Related]

  • 11. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
    Liu JL, Zhu HM, Huang QR, Zhang ZL, Li HL, Qin YJ, Zhang Y, Wei DL, Lu JH, Liu H, Chen XP, Liu YJ, Ekangaki A, Zheng YM, Diez-Perez A, Harper K.
    Chin Med J (Engl); 2004 Jul 15; 117(7):1029-35. PubMed ID: 15265377
    [Abstract] [Full Text] [Related]

  • 12. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
    Yasui T, Miyatani Y, Tomita J, Yamada M, Uemura H, Miura M, Irahara M.
    Gynecol Endocrinol; 2006 Aug 15; 22(8):455-9. PubMed ID: 17012108
    [Abstract] [Full Text] [Related]

  • 13. Oral contraceptives for the prevention of osteoporosis.
    Corson SL.
    J Reprod Med; 1993 Dec 15; 38(12 Suppl):1015-20. PubMed ID: 8120858
    [Abstract] [Full Text] [Related]

  • 14. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density.
    Nappi C, Di Spiezio Sardo A, Greco E, Tommaselli GA, Giordano E, Guida M.
    Obstet Gynecol; 2005 Jan 15; 105(1):53-60. PubMed ID: 15625142
    [Abstract] [Full Text] [Related]

  • 15. Age at first oral contraceptive use as a major determinant of vertebral bone mass in female endurance athletes.
    Hartard M, Kleinmond C, Kirchbichler A, Jeschke D, Wiseman M, Weissenbacher ER, Felsenberg D, Erben RG.
    Bone; 2004 Oct 15; 35(4):836-41. PubMed ID: 15454090
    [Abstract] [Full Text] [Related]

  • 16. Bone mineral density in young, hypothalamic oligoamenorrheic women treated with oral contraceptives.
    Castelo-Branco C, Vicente JJ, Pons F, Martínez de Osaba MJ, Casals E, Vanrell JA.
    J Reprod Med; 2001 Oct 15; 46(10):875-9. PubMed ID: 11725730
    [Abstract] [Full Text] [Related]

  • 17. Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk.
    Reginster JY, Sarkar S, Zegels B, Henrotin Y, Bruyere O, Agnusdei D, Collette J.
    Bone; 2004 Feb 15; 34(2):344-51. PubMed ID: 14962813
    [Abstract] [Full Text] [Related]

  • 18. Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: effects on bone mineral density and metabolism.
    Gambacciani M, Spinetti A, Cappagli B, Taponeco F, Maffei S, Piaggesi L, Fruzzetti F, Fioretti P.
    Maturitas; 1994 Aug 15; 19(2):125-31. PubMed ID: 7968645
    [Abstract] [Full Text] [Related]

  • 19. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
    Yoshimura N, Kasamatsu T, Sakata K, Hashimoto T, Cooper C.
    J Bone Miner Metab; 2002 Aug 15; 20(5):303-10. PubMed ID: 12203037
    [Abstract] [Full Text] [Related]

  • 20. Effect of oral contraceptive treatment on bone mass acquisition in skeletally immature young female rats.
    Eleftheriades MI, Lambrinoudaki IV, Christodoulakos GE, Gregoriou OV, Economou EV, Kouskouni EE, Antoniou AG, Perrea DN, Dontas IA, Raptou PD, Lyritis GP, Creatsas GC.
    Contraception; 2005 May 15; 71(5):362-71. PubMed ID: 15854638
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.